Mechanical Thrombectomy Devices Market Analysis Report | Size, Share & Future Outlook 2030

Coverage: Mechanical Thrombectomy Devices Market covers analysis By Type (Aspiration Catheters, Stent retrievers, Others); Application (Cardiovascular, Peripheral Vascular, Neurovascular), End User (Academic & Research Institutes, Hospitals & Clinics, Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00031450
  • Category : Medical Device
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

The mechanical thrombectomy devices market size is projected to grow from US$ 696.24 million in 2022 to US$ 1,157.24 million by 2030; the market is estimated to record a CAGR of 6.5% during 2022-2030.

Market Insights and Analyst View:



Mechanical thrombectomy devices comprise a wide array of endovascular tools cleared for removing thrombi from the neurovasculature in acute ischemic stroke patients. The quicker and more completely a clot can be removed to restore blood flow to the brain, the better it is for the patient. The most significant benefit to a patient is when mechanical thrombectomy retrieves (or catches) the stroke-causing clot entirely at the first pass or attempt. When the first pass is successful, it avoids repeated clot retrieval attempts, therefore reducing the risk of complications and procedure time.

Companies operating in the mechanical thrombectomy devices market are focusing on strategic developments such as collaborations, expansions, agreements, partnerships, and new product launches, which is helping them to improve their sales, expand their geographic reach, and enhance their capacities to cater to a larger than existing customer base. For instance, in January 2023, Penumbra, Inc. announced the U.S. FDA) clearance and launch of Lightning Flash, a mechanical thrombectomy system on the market. Lightning Flash features Penumbra's novel Lightning Intelligent Aspiration technology, and it comes with dual clot detection algorithms. Together with innovative catheter engineering, Lightning Flash is developed to quickly remove large blood clots in the body, including venous thrombus and pulmonary emboli (PE).

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Mechanical Thrombectomy Devices Market: Strategic Insights

Mechanical Thrombectomy Devices Market

  • CAGR (2023 - 2031)
    6.50%
  • Market Size 2023
    US$ 741.50 Million
  • Market Size 2031
    US$ 1,227.17 Million

Market Dynamics

GROWTH DRIVERS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
FUTURE TRENDS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
OPPORTUNITIES
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX

Key Players

  • Stryker
  • Boston Scientific
  • Medtronic
  • Terumo
  • Johnson & Johnson
  • Penumbra
  • Spectranetics
  • Teleflex
  • Argon Medical Devices

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Type
  • Aspiration Catheters
  • Stent retrievers
  • Others
Application
  • Cardiovascular
  • Peripheral Vascular
  • Neurovascular
End User
  • Academic & Research Institutes
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
Geography
  • North America
  • Europe
  • Asia Pacific
  • South and Central America
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Growth Drivers: 



Elevating Incidences of CVDs and Neurological Diseases



Neurological diseases are disorders of the brain, spine, and the nerves connecting the brain and spine supplying oxygenated blood. The neurovascular systems are heavily dependent on the continuous oxygen and nutrients supplied by the arteries and veins. Thus, a defect in the system can hamper the function, and it may rapidly become a serious issue. Thrombosis has been increasing in diseases such as peripheral vascular, neurovascular, and other diseases. Thrombosis is a biological response that is closely related to cerebral aneurysms, which are balloon-like dilations of blood vessel walls caused by the weakening of the wall layers.

The prevalence of cerebral aneurysms has increased extremely across the globe. As per the Brain Aneurysm Foundation, an estimated 6.7 million people in the US have an unruptured brain aneurysm, or 1 in 50 people. There are almost 5,00,000 mortalities worldwide each year caused by brain aneurysms, and half the fatalities are younger than 50.

As per the American Heart Association, globally, stroke is the second leading cause of mortality, accounting for 11.6% of all deaths in 2019. Ischemic stroke is the most recurrent type, accounting for 62.4% of all stroke cases worldwide in 2019. This type of stroke results in neurological death and long-term adult disability and thus imposes massive health and economic burdens. Globally, 77.19 million individuals experienced an ischemic stroke in 2019, and 63.48 million disability-adjusted life years (DALYs) and 3.29 million deaths were attributable to ischemic stroke. The age-standardized incidence, death, and DALY rates associated with ischemic stroke decreased in both sexes from 1990 to 2019. Thus, the growing incidences of the abovementioned diseases and the severity of these conditions are expected to propel the growth of the thrombectomy devices market during the estimated period.

Report Segmentation and Scope:



The "Mechanical Thrombectomy Devices Market" is segmented on the basis of type, application, and end users. Based on type, the market is aspiration catheters, stent retrievers, and others. Based on application, the market is segmented into cardiovascular, peripheral vascular, neurovascular, and others. Based on end-user, the market is segmented into academic & research institutes, hospitals & clinics, and ambulatory surgical centers.

Segmental Analysis:



Based on product, the mechanical thrombectomy devices market is divided into aspiration catheters, stent retrievers, and others. Aspiration catheters are flexible with a large inner distal diameter. A guide wire is inserted into the patient, followed by a small access catheter. The access catheter is then used to guide the aspiration catheter to the right place. When the clot is reached, it is broken into smaller pieces that can be aspirated through the catheter using a pump or manual suction.

Stent retrievers have an expanding wire mesh tube and are intended to remove the clot in 1 piece. The retriever is placed using a delivery catheter, and once in place, the mesh expands. The clot is trapped in the expanding mesh and is then withdrawn into the catheter.

Based on application, the mechanical thrombectomy devices market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering, regenerative medicine, and others. In 2022, the cardiovascular segment held the largest share of the market. However, a peripheral vascular segment is expected to grow at the fastest rate during the coming year. Peripheral vascular disease (PVD) is a blood flow disorder that causes the brain to block, narrow, or spasm. The procedure is employed to eliminate emboli and thrombi from vessels of the venous systems and peripheral arterial. These minimally invasive devices are used to enable the fast restoration of blood flow in such cases as acute limb ischemia and deep vein thrombosis.

Additionally, acute embolism and thrombosis are the most common cause of peripheral vascular occlusion. The disease can be treated by surgeries that include peripheral vascular devices such as catheters, stents, guidewires, and others. These devices differ in the method of fluid delivery to achieve rapid flow rates.

Based on end user, the mechanical thrombectomy devices market is segmented into pharmaceutical and biotechnology companies, contract research organizations and contract manufacturing organizations, and academic and research institutes. The hospitals segment held the largest share of the market in 2022. Moreover, the same is expected to register the highest CAGR in the market during the forecast period. Pharmaceutical companies hold a major share of the total medicine production. Owing to the development in healthcare facilities, hospitals are advanced with modernized equipment and are installed with digital pathology and artificial intelligence. These technologies assist in communicating in the inter-departments and also allow the sharing of data across the domain. The clinics offer diagnosis and the treatment of neurologic conditions such as cerebrovascular diseases and strokes, multiple sclerosis, neuro-oncology, and others. Besides, the rise in the prevalence of neurologic cardiovascular disorders such as stroke and brain aneurysms is driving the growth of hospitals.

Regional Analysis:



Based on geography, the global mechanical thrombectomy devices market is segmented into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. In 2022, North America contributed the largest share of the global mechanical thrombectomy devices market size. Asia Pacific is expected to register the highest CAGR during 2022-2030.

North America holds the largest share of the mechanical thrombectomy devices market. The market in this region is split into the US, Canada, and Mexico. The growth of the market in the region is attributed to factors such as the growth of the market, which is attributed to growing advancements in thrombectomy devices and rising cardiovascular diseases in the region.

The US is the largest contributor to the mechanical thrombectomy devices market in North America and the world. Market growth in the US is mainly attributed to the rising prevalence of cardiovascular diseases. As per the American Heart Association, one of every three deaths is caused by cardiovascular diseases in the US. Moreover, every year, ~2,300 Americans die because of cardiovascular disease, and an average of one death is recorded every 38 seconds. As per the CDC, about 695,000 people in the US died from heart disease in 2021; that’s 1 in every five deaths. As per the same source, in 2020, there were 7.08 million deaths attributable to cerebrovascular disease worldwide (3.48 million deaths from ischemic stroke, 3.25 million deaths from intracerebral hemorrhage (ICH), and 0.35 million from subarachnoid hemorrhage). Growing cerebrovascular diseases will propel the neurovascular thrombectomy devices market.

Furthermore, in 2020, Royal Philips launched its innovative QuickClear mechanical thrombectomy system. The compact, single-use system offers an all-in-one aspiration pump and catheter for the elimination of blood clots from the peripheral arterial and venous vessels. The system’s innovative all-in-one design is simple to use while removing the necessity for capital equipment or costly accessories, with easy arrangement supporting faster procedure times. This QuickClear Mechanical Thrombectomy System has received U.S. FDA 510(k) approval and is available for sale in the U.S.

Thus, growing advancements in thrombectomy devices and rising cardiovascular and cerebrovascular diseases in the region are expected to drive the mechanical thrombectomy market.

Industry Developments and Future Opportunities:



Various initiatives taken by leading players operating in the mechanical thrombectomy devices market are listed below:

  1. In February 2022, Imperative Care, Inc. launched Zoom POD Aspiration Tubing, the company's latest innovation in elevating stroke care. This newest addition to the company's Zoom Stroke Solution allows quick confirmation of successful clot retrieval during mechanical thrombectomy for ischemic stroke.
  2. In October 2021, phenox introduced the pRESET 6-50 mechanical thrombectomy device to treat acute large vessel occlusive (LVO) stroke.
  3. In September 2021, Boston Scientific Corporation acquired Devoro Medical, Inc., the WOLF Thrombectomy Platform developer, to add a mechanical thrombectomy platform to the peripheral interventions portfolio. The innovative non-console and lytic-free WOLF technology targets and captures blood clots using finger-like prongs that retrieve and remove thrombi in the arterial and venous systems.
  4. In December 2019, Vascular Medcure, Inc. received FDA clearance for its latest CAPERE Thrombectomy System, a mechanical device for treating peripheral vascular deep vein thrombosis (DVT).
  5. In April 2019, Medtronic launched Solitaire X revascularization device for treating acute ischemic stroke in the U.S. Solitaire stent retriever uses a micro-sized catheter to access arteries in the brain, restoring blood flow and removing blood clots that cause acute ischemic stroke.

Competitive Landscape and Key Companies:



Stryker, Boston Scientific, Medtronic, Terumo, Johnson & Johnson, Penumbra, Spectranetics, Teleflex, Argon Medical Devices, and Edwards Lifesciences are the prominent mechanical thrombectomy devices market companies. These companies focus on new technologies, existing product advancements, and geographic expansions to meet the growing consumer demand worldwide.

Mechanical Thrombectomy Devices Market Report Scope

Report Attribute Details
Market size in 2023 US$ 741.50 Million
Market Size by 2031 US$ 1,227.17 Million
Global CAGR (2023 - 2031) 6.50%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Type
  • Aspiration Catheters
  • Stent retrievers
  • Others
By Application
  • Cardiovascular
  • Peripheral Vascular
  • Neurovascular
By End User
  • Academic & Research Institutes
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Stryker
  • Boston Scientific
  • Medtronic
  • Terumo
  • Johnson & Johnson
  • Penumbra
  • Spectranetics
  • Teleflex
  • Argon Medical Devices
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    • Stryker
    • Boston Scientific
    • Medtronic
    • Terumo
    • Johnson & Johnson
    • Penumbra
    • Spectranetics
    • Teleflex
    • Argon Medical Devices
    • Edwards Lifesciences

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • 3.1 Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • 3.2 Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • 3.3 Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • 3.4 Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Trends and growth analysis reports related to Mechanical Thrombectomy Devices Market